Mukae H, Sakito O, Oda H, Senju R, Fukushima K, Hiratani K, Kadota J, Komori K, Kohno S, Hara K
Second Department of Internal Medicine, Nagasaki University School of Medicine.
Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30(12):2075-81.
It is known that tumor associated carbohydrate antigens are significantly increased in the serum of patients with diffuse panbronchiolitis (DPB). We investigated carbohydrate antigens (SLX, CA19-9) in bronchoalveolar lavage fluid (BALF) obtained from 24 patients with DPB. The concentrations of SLX and CA19-9 were significantly higher in BALF from patients with DPB than those from healthy subjects (7 cases) and patients with pulmonary sarcoidosis (16 cases). No significant correlation was observed between either SLX or CA19-9 concentrations in the serum and BALF, and no significant correlation was observed between the concentrations of these carbohydrate antigens in BALF and clinical findings. Immunohistochemical study of SLX and CA19-9 in open lung biopsy specimens obtained from patients with DPB showed expression of SLX and CA19-9 on the bronchiolar surface epithelial cells and mucinous exudates in air spances. These results indicate that carbohydrate antigens are presumably increased in the pulmonary lesions of patients with DPB, and this increase causes high levels of these antigens in the serum. Furthermore, we investigated the change of concentrations of SLX and CA19-9 in BALF obtained from patients with DPB after erythromycin (EM) treatment. The concentrations of these two antigens were decreased after EM treatment.
已知弥漫性泛细支气管炎(DPB)患者血清中肿瘤相关碳水化合物抗原显著增加。我们研究了从24例DPB患者获取的支气管肺泡灌洗液(BALF)中的碳水化合物抗原(SLX、CA19-9)。DPB患者BALF中SLX和CA19-9的浓度显著高于健康受试者(7例)和结节病患者(16例)。血清和BALF中SLX或CA19-9的浓度之间未观察到显著相关性,且BALF中这些碳水化合物抗原的浓度与临床发现之间也未观察到显著相关性。对DPB患者开胸肺活检标本进行的SLX和CA19-9免疫组化研究显示,SLX和CA19-9在细支气管表面上皮细胞和肺泡腔中的黏液性渗出物上表达。这些结果表明,DPB患者肺部病变中碳水化合物抗原可能增加,这种增加导致血清中这些抗原水平升高。此外,我们研究了DPB患者在接受红霉素(EM)治疗后BALF中SLX和CA19-9浓度的变化。EM治疗后这两种抗原的浓度降低。